Search results
New Alzheimer’s drug wins approval after FDA delay
Deseret News· 3 hours agoPatients and their families will have to weigh that benefit against the downsides, including regular IV infusions and potentially dangerous side effects...
These two stocks can act as Rahul Dravid of your portfolio: Gautam Shah
The Economic Times· 21 hours agoGautam Shah: Well, pharma has been a brilliant story for the last one year. Now it saw a breakout...